Hims & Hers Health, Inc.
corporate_fare Company Profile
Hims & Hers Health, Inc. (NYSE:HIMS) is a publicly traded company in the Consumer Defensive sector. Wiseek monitors HIMS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Hims & Hers Prices Upsized $350M Convertible Notes at 32.5% Premium for Growth
- Hims & Hers Prices Upsized $350M Convertible Notes for Global Expansion, AI Investment
- Hims & Hers Health Plans $300M Convertible Notes Offering for Global Expansion, AI
- Surprise Q1 Loss Sends Hims & Hers Down 16% as Branded Weight-Loss Drug Pivot Hits Margins
- Hims & Hers Reports Q1 Net Loss, Lower EBITDA Amid Restructuring & Legal Accruals
monitoring Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$2.35B
Net Income
$128.37M
Diluted EPS
$0.51
Op. Cash Flow
$300.01M
Free Cash Flow
$57.41M
Gross Profit
$1.73B
Operating Income
$105.61M
Cash & Equivalents
$228.62M
Total Debt
$972.58M
Debt / Equity
1.80×
Net Margin
5.5%
Shares Outstanding
224.96M sh
Source: 10-K · filed 2026-02-23 · accession 0001773751-26-000022
supervised_user_circle Insider Transactions
$127.47M sold
Net $127.47M selling
· 100 transactions by 8 insiders · last 12 months
-
2026-05-18 Okupe Oluyemi Chief Financial Officer OfficerOpen-market sale 7.95K sh $187.92K @ $23.64
-
2026-04-20 Boughton Soleil Chief Legal Officer OfficerOpen-market sale 9.46K sh $283.89K @ $30.00
-
2026-04-20 Okupe Oluyemi Chief Financial Officer OfficerOpen-market sale 19.64K sh $588.62K @ $29.96
-
2026-04-17 Okupe Oluyemi Chief Financial Officer OfficerOpen-market sale 18K sh $501.16K @ $27.83
-
2026-04-16 Okupe Oluyemi Chief Financial Officer OfficerOpen-market sale 36.92K sh $956.15K @ $25.90
-
2026-04-06 Okupe Oluyemi Chief Financial Officer OfficerOpen-market sale 3.98K sh $79.41K @ $19.98
-
2026-03-20 Okupe Oluyemi Chief Financial Officer OfficerOpen-market sale 9.22K sh $219.07K @ $23.77
-
2026-03-17 Boughton Soleil Chief Legal Officer OfficerOpen-market sale 4.81K sh $118.81K @ $24.69
-
2026-03-17 Becklund Irene PAO OfficerOpen-market sale 5.53K sh $136.51K @ $24.69
-
2026-05-18 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 7.95K sh derivative
-
2026-05-18 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 7.95K sh $39.83K @ $5.01
-
2026-04-20 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 12.55K sh 2 fills derivative
-
2026-04-20 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 12.55K sh $108.53K 2 fills, avg $8.65
-
2026-04-17 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 6.18K sh $30.98K @ $5.01
-
2026-04-17 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 6.18K sh derivative
-
2026-04-06 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 3.98K sh derivative
-
2026-04-06 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 3.98K sh $19.91K @ $5.01
-
2026-03-20 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 4.49K sh derivative
-
2026-03-20 Okupe Oluyemi Chief Financial Officer OfficerOption exercise 4.49K sh $22.49K @ $5.01
-
2026-04-09 Dudum Andrew Chief Executive Officer Officer · Director · 10% OwnerGift 845.87K sh 2 fills
From SEC Form 4 + 5 (insider beneficial-ownership filings) · last 12 months · view all on SEC EDGAR ↑
show_chartPrice Chart
Loading chart...
feed HIMS - Latest Insights
HIMS
May 19, 2026, 8:17 AM EDT
HIMS
May 19, 2026, 12:08 AM EDT
HIMS
May 18, 2026, 7:17 AM EDT
HIMS
May 12, 2026, 7:28 AM EDT
HIMS
May 11, 2026, 4:15 PM EDT
HIMS
May 11, 2026, 4:08 PM EDT
HIMS
May 11, 2026, 4:06 PM EDT
HIMS
Apr 28, 2026, 8:23 AM EDT
HIMS
Apr 22, 2026, 11:22 AM EDT
HIMS
Apr 16, 2026, 11:31 AM EDT
HIMS
Apr 02, 2026, 5:28 PM EDT
HIMS
Mar 27, 2026, 4:04 PM EDT
HIMS
Mar 11, 2026, 5:21 PM EDT
HIMS
Mar 11, 2026, 4:03 PM EDT
HIMS
Mar 09, 2026, 7:43 AM EDT
HIMS
Mar 03, 2026, 10:33 AM EST
HIMS
Feb 23, 2026, 5:20 PM EST
HIMS
Feb 23, 2026, 4:07 PM EST
HIMS
Feb 19, 2026, 6:19 AM EST